Latest News about NVO
Recent news which mentions NVO
Better Blockbuster-Drug Stock: Novo Nordisk vs. Eli Lilly
March 03, 2024
From Motley Fool
From Motley Fool
3 Magnificent Growth Stocks to Buy in March
March 02, 2024
From Motley Fool
Why Novo Nordisk Stock Topped the Market Today
March 01, 2024
From Motley Fool
Eli Lilly's Commercial Moat, Competitor Landscape: BofA Emphasizes Strength in Incretin Space, Undervalued Assets
March 01, 2024
From Benzinga
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
March 01, 2024
From Motley Fool
These 4 Stocks Are the "Magnificent Seven" of Healthcare
March 01, 2024
From Motley Fool
Ozempic, Wegovy Other Weight-Loss Drugs Won't Solve Global Obesity Crisis Affecting 1B People, WHO Warns
March 01, 2024
From Benzinga
5 Investors Betting Big on Weight Watchers (WW) Stock as Oprah Backs Out
February 29, 2024
From InvestorPlace
From Benzinga
From Motley Fool
From Motley Fool
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
February 28, 2024
From Benzinga
Why Is Vivani Medical (VANI) Stock Up 300% Today?
February 28, 2024
From InvestorPlace
Viking Therapeutics' Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say
February 28, 2024
From Benzinga
From InvestorPlace
Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss
February 28, 2024
From Benzinga
Miracle Or Myth? Survey Shows Americans Doubt Ozempic, Wegovy's Weight Loss Claims
February 28, 2024
From Benzinga
EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows
February 28, 2024
From Benzinga
Why Novo Nordisk and Eli Lilly Stocks Slipped Today
February 27, 2024
From Motley Fool
The 3 Hottest Healthcare ETFs to Buy in 2024
February 26, 2024
From InvestorPlace
Future Juggernauts: The Next 7 Trillion Dollar Companies to Buy Now
February 26, 2024
From InvestorPlace
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs
February 26, 2024
From Benzinga
From Benzinga
Tickers
NVO
From Motley Fool
Obesity Solutions Like Weight Loss Drugs To Act As Catalyst For Economic Surge, Goldman Sachs Forecasts
February 23, 2024
From Benzinga
Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand
February 22, 2024
From Benzinga
Move Over Magnificent 7, Say Hello to the GRANOLAS
February 22, 2024
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.